Text Size
182 studies found for:    Open Studies | "Heparin"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Heparin" (182 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
2 Recruiting DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
3 Recruiting Safety of Heparin in Patients With Septic Shock
Condition: Sepsis
Intervention: Drug: heparin
4 Unknown † OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis
Conditions: Renal Failure;   Hemodialysis
Interventions: Drug: law molecular weigth heparin;   Drug: unfractioned heparin
5 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
6 Recruiting Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
Condition: Venous Thrombosis
Interventions: Drug: low dose intravenous heparin (LDIVH);   Drug: Heparin
7 Recruiting Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Abraxane ( Nab-paclitaxel);   Drug: Gemcitabine;   Drug: ODSH ( 2-O, 3-O Desulfated Heparin);   Drug: Abraxane ( nab-paclitaxel)
8 Recruiting Understanding "Heparin Resistance" in Cardiac Surgery
Conditions: Cardiopulmonary Bypass;   Altered Heparin Response
Interventions: Drug: Heparin;   Drug: ATryn
9 Unknown † Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: bovine heparin;   Biological: Porcine heparin
10 Unknown † Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Biological: heparin sodium
11 Unknown † Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP
12 Recruiting Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Conditions: Obesity;   Morbid Obesity;   Venous Thromboembolism;   Atrial Fibrillation;   Angina;   Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
13 Recruiting Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: Prasugrel;   Drug: Bivalirudin;   Drug: Clopidogrel;   Drug: Heparin
14 Not yet recruiting Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Conditions: Inhalation Injury;   Burn Injury
Interventions: Drug: unfractionated heparin;   Drug: placebo
15 Unknown † Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: Bovine Heparin;   Biological: Porcine heparin
16 Not yet recruiting PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
17 Not yet recruiting PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
18 Recruiting ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
19 Recruiting Propaten Randomized Investigation on Cost-benefit and Efficacy
Condition: End-stage Renal Disease
Interventions: Device: Heparin-bonded vascular access graft;   Device: Conventional ePTFE hemodialysis graft
20 Unknown † Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
Conditions: Acute Kidney Injury;   Hemodialysis
Interventions: Drug: Unfractionated heparin;   Drug: Citrasate
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years